A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
Rethinking Carpeting's Role in Senior Care Facilities
Parkview Health Breaks Ground on New Hospital in West Lafayette, IN
Loma Linda University Health Experiences Data Breach via AI Tool
Inside One of Healthcare's Most Ambitious Hospital Projects 
Turning Condensate Loss into a Systemwide Steam Efficiency Opportunity